Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 26, 2020 Filed Nov 30, 2020 21:34 UTC |
Spoerel Thomas JVP Controller & Chief Acct Off
|
Tax withholdingCommon Stock | 222 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000050 · edgar.xml · nonDerivative · entry 2 Spoerel Thomas J · CIK 0001790223 · VP Controller & Chief Acct Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,011 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2020 Filed Nov 30, 2020 21:34 UTC |
Spoerel Thomas JVP Controller & Chief Acct Off
|
GrantCommon Stock | 257 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000050 · edgar.xml · nonDerivative · entry 1 Spoerel Thomas J · CIK 0001790223 · VP Controller & Chief Acct Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,233 F1 · shares: Represents shares vesting under performance units granted on November 26, 2017. Read SEC document |
| November 26, 2020 Filed Nov 30, 2020 21:23 UTC |
Polen Thomas E JrExecutive Vice President
|
GrantStock Appreciation Rights · Derivative | 92,298 | $0.00 Strike: $227.47 | $0.00 |
DisclosureSEC source: 0001543407-20-000049 · edgar.xml · derivative · entry 3 Polen Thomas E Jr · CIK 0001621793 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,298 Underlying: Common Stock · 92,298 shares Expires 2030-11-26 F3 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2021. Read SEC document |
| November 26, 2020 Filed Nov 30, 2020 21:23 UTC |
Polen Thomas E JrExecutive Vice President
|
Tax withholdingCommon Stock | 2,352 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000049 · edgar.xml · nonDerivative · entry 2 Polen Thomas E Jr · CIK 0001621793 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,422 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2020 Filed Nov 30, 2020 21:23 UTC |
Polen Thomas E JrExecutive Vice President
|
GrantCommon Stock | 2,657 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000049 · edgar.xml · nonDerivative · entry 1 Polen Thomas E Jr · CIK 0001621793 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,774 F1 · shares: Represents shares vesting under performance units granted on November 26, 2017. Read SEC document |
| November 26, 2020 Filed Nov 30, 2020 20:45 UTC |
Kaltenbach PatrickEVP & Pres Life Sciences
|
GrantRights to Common Stock Under BD Deferred Compensation Plan · Derivative | 621 | $227.47 | $141,258.87 |
DisclosureSEC source: 0001543407-20-000048 · edgar.xml · derivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 621 Underlying: Common Stock · 621 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's servicer, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's servicer, or on the date or dates specified by the reporting person. Read SEC document |
| November 26, 2020 Filed Nov 30, 2020 20:35 UTC |
FORLENZA VINCENT ADirector · Chairman of the Board
|
Tax withholdingCommon Stock | 7,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000047 · edgar.xml · nonDerivative · entry 5 FORLENZA VINCENT A · CIK 0001221787 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,316 F3 · shares: Represents shares withheld for payment of withholding taxes in connection with vesting of the performance units referred to in footnote (1) and the vesting of restricted stock units as previously reported on Table 1. Read SEC document |
| November 26, 2020 Filed Nov 30, 2020 20:35 UTC |
FORLENZA VINCENT ADirector · Chairman of the Board
|
GrantCommon Stock | 7,969 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000047 · edgar.xml · nonDerivative · entry 4 FORLENZA VINCENT A · CIK 0001221787 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,396 F2 · shares: Represents shares vesting under performance units granted on November 26, 2017. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:52 UTC |
Goette RolandEVP and President, EMEA
|
Exercise / conversionStock Appreciation Rights · Derivative | 3,485 | $0.00 Strike: $76.64 | $0.00 |
DisclosureSEC source: 0001543407-20-000046 · edgar.xml · derivative · entry 5 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,485 shares Expires 2020-11-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 23, 2011. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:52 UTC |
Goette RolandEVP and President, EMEA
|
SaleCommon Stock | 930 | $230.10 | $213,993.00 |
DisclosureSEC source: 0001543407-20-000046 · edgar.xml · nonDerivative · entry 3 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,994 F1 · balance_after: Includes 1,394 gain shares held by reporting person from the exercise of the stock appreciation right. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:52 UTC |
Goette RolandEVP and President, EMEA
|
Disposition to issuerCommon Stock | 1,161 | $230.10 | $267,146.10 |
DisclosureSEC source: 0001543407-20-000046 · edgar.xml · nonDerivative · entry 2 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,924 Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:52 UTC |
Goette RolandEVP and President, EMEA
|
Exercise / conversionCommon Stock | 3,485 | $76.64 | $267,090.40 |
DisclosureSEC source: 0001543407-20-000046 · edgar.xml · nonDerivative · entry 1 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,085 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2020 Filed Nov 30, 2020 20:35 UTC |
FORLENZA VINCENT ADirector · Chairman of the Board
|
GiftCommon Stock | 462 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000047 · edgar.xml · nonDerivative · entry 3 FORLENZA VINCENT A · CIK 0001221787 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,427 Read SEC document |
| November 12, 2020 Filed Nov 30, 2020 20:35 UTC |
FORLENZA VINCENT ADirector · Chairman of the Board
|
GiftCommon Stock | 104 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000047 · edgar.xml · nonDerivative · entry 2 FORLENZA VINCENT A · CIK 0001221787 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,889 Read SEC document |
| November 10, 2020 Filed Nov 30, 2020 20:35 UTC |
FORLENZA VINCENT ADirector · Chairman of the Board
|
GiftCommon Stock | 7,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000047 · edgar.xml · nonDerivative · entry 1 FORLENZA VINCENT A · CIK 0001221787 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,993 F1 · shares: These shares were previously reported as held in a grantor retained annuity trust and were distributed to the reporting person on November 10, 2020. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 14:46 UTC |
SCOTT BERTRAM LDirector
|
GrantRights to Common Stock Under 1996 Directors Deferral Plan · Derivative | 115 | $237.66 | $27,330.90 |
DisclosureSEC source: 0001543407-20-000045 · edgar.xml · derivative · entry 1 SCOTT BERTRAM L · CIK 0001221780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,887 Underlying: Common Stock · 115 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 14:45 UTC |
Jones Christopher Ian MontagueDirector
|
GrantRights to Common Stock Under 1996 Directors Deferral Plan · Derivative | 115 | $237.66 | $27,330.90 |
DisclosureSEC source: 0001543407-20-000044 · edgar.xml · derivative · entry 1 Jones Christopher Ian Montague · CIK 0001292762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,466 Underlying: Common Stock · 115 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 14:49 UTC |
Spoerel Thomas JVP Controller & Chief Acct Off
|
Tax withholdingCommon Stock | 59 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000041 · edgar.xml · nonDerivative · entry 1 Spoerel Thomas J · CIK 0001790223 · VP Controller & Chief Acct Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 976 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| August 13, 2020 Filed Aug 14, 2020 19:29 UTC |
SCOTT BERTRAM LDirector
|
GrantRights to Common Stock Under 1996 Directors Deferral Plan · Derivative | 57 | $261.50 | $14,905.50 |
DisclosureSEC source: 0001543407-20-000040 · edgar.xml · derivative · entry 1 SCOTT BERTRAM L · CIK 0001221780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,619 Underlying: Common Stock · 57 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| August 13, 2020 Filed Aug 14, 2020 19:27 UTC |
Jones Christopher Ian MontagueDirector
|
GrantRights to Common Stock Under 1996 Directors Deferral Plan · Derivative | 57 | $261.50 | $14,905.50 |
DisclosureSEC source: 0001543407-20-000039 · edgar.xml · derivative · entry 1 Jones Christopher Ian Montague · CIK 0001292762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,328 Underlying: Common Stock · 57 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| July 14, 2020 Filed Jul 16, 2020 17:31 UTC |
Kaltenbach PatrickEVP & Pres Life Sciences
|
GrantRights to Common Stock Under BD Deferred Compensation Plan · Derivative | 620 | $263.40 | $163,308.00 |
DisclosureSEC source: 0001543407-20-000038 · edgar.xml · derivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 620 Underlying: Common Stock · 620 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's servicer, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's servicer, or on the date or dates specified by the reporting person. Read SEC document |
| July 10, 2020 Filed Sep 29, 2020 17:37 UTC |
FORLENZA VINCENT ADirector · Chairman of the Board
|
GiftCommon Stock | 11,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000042 · edgar.xml · nonDerivative · entry 3 FORLENZA VINCENT A · CIK 0001221787 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,486 Read SEC document |
| July 09, 2020 Filed Jul 13, 2020 13:31 UTC |
Kaltenbach PatrickEVP & Pres Life Sciences
|
SaleCommon Stock | 1,272 | $260.00 | $330,720.00 |
DisclosureSEC source: 0001543407-20-000037 · edgar.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,340 F1 · price: This transaction was made pursuant to a 10b5-1 plan entered into on December 13, 2019. Read SEC document |
| June 30, 2020 Filed Sep 29, 2020 17:37 UTC |
FORLENZA VINCENT ADirector · Chairman of the Board
|
GiftCommon Stock | 21,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000042 · edgar.xml · nonDerivative · entry 2 FORLENZA VINCENT A · CIK 0001221787 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,146 Read SEC document |
| June 05, 2020 Filed Jun 5, 2020 19:07 UTC |
Kaltenbach PatrickEVP & Pres Life Sciences
|
SaleCommon Stock | 1,049 | $243.20 | $255,116.80 |
DisclosureSEC source: 0001543407-20-000036 · edgar.xml · nonDerivative · entry 2 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,612 F2 · price: This transaction was made pursuant to a 10b5-1 plan entered into on December 13, 2019. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 19:07 UTC |
Kaltenbach PatrickEVP & Pres Life Sciences
|
Tax withholdingCommon Stock | 2,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000036 · edgar.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,661 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| June 02, 2020 Filed Jun 2, 2020 18:24 UTC |
Kaltenbach PatrickEVP & Pres Life Sciences
|
SaleCommon Stock | 222 | $244.83 | $54,352.26 |
DisclosureSEC source: 0001543407-20-000035 · edgar.xml · nonDerivative · entry 2 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,688 F2 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $244.83 through $244.91. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on December 13, 2019. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 18:24 UTC |
Kaltenbach PatrickEVP & Pres Life Sciences
|
Tax withholdingCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000035 · edgar.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,910 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| May 27, 2020 Filed May 29, 2020 17:25 UTC |
SCOTT BERTRAM LDirector
|
GrantRights to Common Stock Under 1996 Directors Deferral Plan · Derivative | 106 | $234.59 | $24,866.54 |
DisclosureSEC source: 0001543407-20-000033 · edgar.xml · derivative · entry 1 SCOTT BERTRAM L · CIK 0001221780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,562 Underlying: Common Stock · 106 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 27, 2020 Filed May 29, 2020 17:25 UTC |
Jones Christopher Ian MontagueDirector
|
GrantRights to Common Stock Under 1996 Directors Deferral Plan · Derivative | 106 | $234.59 | $24,866.54 |
DisclosureSEC source: 0001543407-20-000034 · edgar.xml · derivative · entry 1 Jones Christopher Ian Montague · CIK 0001292762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,271 Underlying: Common Stock · 106 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 13, 2020 Filed Sep 29, 2020 17:37 UTC |
FORLENZA VINCENT ADirector · Chairman of the Board
|
GiftCommon Stock | 10,474 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000042 · edgar.xml · nonDerivative · entry 1 FORLENZA VINCENT A · CIK 0001221787 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,338 F1 · shares: These shares were previously reported as held in a grantor retained annuity trust and were distributed to the reporting person on May 13, 2020. Read SEC document |
| May 08, 2020 Filed May 8, 2020 18:29 UTC |
Fraser ClaireDirector
|
SaleCommon Stock | 771 | $256.56 | $197,807.76 |
DisclosureSEC source: 0001543407-20-000032 · edgar.xml · nonDerivative · entry 1 Fraser Claire · CIK 0001382031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,168 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $256.46 through $256.57. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 17:03 UTC |
Khichi Samrat S.EVP and General Counsel
|
SaleCommon Stock | 4,349 | $224.53 | $976,480.97 |
DisclosureSEC source: 0001543407-20-000030 · edgar.xml · nonDerivative · entry 2 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,262 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $211.05 through $232.75. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on March 2, 2020. Read SEC document |
| February 19, 2020 Filed Mar 17, 2020 17:03 UTC |
Khichi Samrat S.EVP and General Counsel
|
GiftCommon Stock | 195 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000030 · edgar.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,611 Read SEC document |
| February 14, 2020 Filed Feb 14, 2020 14:13 UTC |
Jones Christopher Ian MontagueDirector
|
GrantRights to Common Stock Under 1996 Directors Deferral Plan · Derivative | 188 | $275.18 | $51,733.84 |
DisclosureSEC source: 0001543407-20-000028 · edgar.xml · derivative · entry 1 Jones Christopher Ian Montague · CIK 0001292762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,165 Underlying: Common Stock · 188 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| February 14, 2020 Filed Feb 14, 2020 14:16 UTC |
SCOTT BERTRAM LDirector
|
GrantRights to Common Stock Under 1996 Directors Deferral Plan · Derivative | 188 | $275.18 | $51,733.84 |
DisclosureSEC source: 0001543407-20-000029 · edgar.xml · derivative · entry 1 SCOTT BERTRAM L · CIK 0001221780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,456 Underlying: Common Stock · 188 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| February 11, 2020 Filed Feb 11, 2020 20:17 UTC |
Fraser ClaireDirector
|
SaleCommon Stock | 700 | $258.70 | $181,090.00 |
DisclosureSEC source: 0001543407-20-000024 · edgar.xml · nonDerivative · entry 2 Fraser Claire · CIK 0001382031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,939 F1 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| February 11, 2020 Filed Feb 11, 2020 20:17 UTC |
Fraser ClaireDirector
|
SaleCommon Stock | 800 | $258.73 | $206,984.00 |
DisclosureSEC source: 0001543407-20-000024 · edgar.xml · nonDerivative · entry 1 Fraser Claire · CIK 0001382031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,639 F1 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 20:50 UTC |
Larson Betty DEVP HR & CHRO
|
Tax withholdingCommon Stock | 968 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000025 · edgar.xml · nonDerivative · entry 1 Larson Betty D · CIK 0001617903 · EVP HR & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,337 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 21:10 UTC |
Khichi Samrat S.EVP and General Counsel
|
Tax withholdingCommon Stock | 2,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000027 · edgar.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,806 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 21:03 UTC |
Campion Simon DEVP and Segment President
|
Tax withholdingCommon Stock | 1,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000026 · edgar.xml · nonDerivative · entry 1 Campion Simon D · CIK 0001751919 · EVP and Segment President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,643 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| February 04, 2020 Filed Feb 5, 2020 19:48 UTC |
Campion Simon DEVP and Segment President
|
Exercise / conversionStock Appreciation Rights · Derivative | 2,891 | $0.00 Strike: $143.07 | $0.00 |
DisclosureSEC source: 0001543407-20-000023 · edgar.xml · derivative · entry 20 Campion Simon D · CIK 0001751919 · EVP and Segment President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 963 Underlying: Common Stock · 2,891 shares Expires 2026-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning December 14, 2017. Read SEC document |
| February 04, 2020 Filed Feb 5, 2020 19:48 UTC |
Campion Simon DEVP and Segment President
|
Exercise / conversionStock Appreciation Rights · Derivative | 4,783 | $0.00 Strike: $121.49 | $0.00 |
DisclosureSEC source: 0001543407-20-000023 · edgar.xml · derivative · entry 19 Campion Simon D · CIK 0001751919 · EVP and Segment President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,783 shares Expires 2025-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning December 9, 2016. Read SEC document |
| February 04, 2020 Filed Feb 5, 2020 19:48 UTC |
Campion Simon DEVP and Segment President
|
Exercise / conversionStock Appreciation Rights · Derivative | 3,089 | $0.00 Strike: $110.04 | $0.00 |
DisclosureSEC source: 0001543407-20-000023 · edgar.xml · derivative · entry 18 Campion Simon D · CIK 0001751919 · EVP and Segment President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,089 shares Expires 2024-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning December 10, 2015. Read SEC document |
| February 04, 2020 Filed Feb 5, 2020 19:48 UTC |
Campion Simon DEVP and Segment President
|
Exercise / conversionStock Appreciation Rights · Derivative | 2,326 | $0.00 Strike: $88.87 | $0.00 |
DisclosureSEC source: 0001543407-20-000023 · edgar.xml · derivative · entry 17 Campion Simon D · CIK 0001751919 · EVP and Segment President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,326 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning December 11, 2014. Read SEC document |
| February 04, 2020 Filed Feb 5, 2020 19:48 UTC |
Campion Simon DEVP and Segment President
|
Exercise / conversionStock Appreciation Rights · Derivative | 523 | $0.00 Strike: $63.66 | $0.00 |
DisclosureSEC source: 0001543407-20-000023 · edgar.xml · derivative · entry 16 Campion Simon D · CIK 0001751919 · EVP and Segment President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 523 shares Expires 2022-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning December 12, 2013. Read SEC document |
| February 04, 2020 Filed Feb 5, 2020 19:48 UTC |
Campion Simon DEVP and Segment President
|
SaleCommon Stock | 1,439 | $285.09 | $410,244.51 |
DisclosureSEC source: 0001543407-20-000023 · edgar.xml · nonDerivative · entry 15 Campion Simon D · CIK 0001751919 · EVP and Segment President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,773 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $285.00 through $285.43. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on December 16, 2019. Read SEC document |
| February 04, 2020 Filed Feb 5, 2020 19:48 UTC |
Campion Simon DEVP and Segment President
|
Disposition to issuerCommon Stock | 1,452 | $285.09 | $413,950.68 |
DisclosureSEC source: 0001543407-20-000023 · edgar.xml · nonDerivative · entry 14 Campion Simon D · CIK 0001751919 · EVP and Segment President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,212 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $285.00 through $285.43. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on December 16, 2019. Read SEC document |
| February 04, 2020 Filed Feb 5, 2020 19:48 UTC |
Campion Simon DEVP and Segment President
|
Exercise / conversionCommon Stock | 2,891 | $143.07 | $413,615.37 |
DisclosureSEC source: 0001543407-20-000023 · edgar.xml · nonDerivative · entry 13 Campion Simon D · CIK 0001751919 · EVP and Segment President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2020 Filed Feb 5, 2020 19:48 UTC |
Campion Simon DEVP and Segment President
|
SaleCommon Stock | 2,744 | $285.09 | $782,286.96 |
DisclosureSEC source: 0001543407-20-000023 · edgar.xml · nonDerivative · entry 12 Campion Simon D · CIK 0001751919 · EVP and Segment President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,773 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $285.00 through $285.43. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on December 16, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.